Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology

This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation. Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biological psychiatry (1969) 2005-05, Vol.57 (10), p.1176-1185
Hauptverfasser: TSALTAS, Eleftheria, KONTIS, Dimitris, CHRYSIKAKOU, Sofia, GIANNOU, Haralambos, BIBA, Angeliki, PALLIDI, Stella, CHRISTODOULOU, Angeliki, MAILLIS, Antonis, RABAVILAS, Andreas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1185
container_issue 10
container_start_page 1176
container_title Biological psychiatry (1969)
container_volume 57
creator TSALTAS, Eleftheria
KONTIS, Dimitris
CHRYSIKAKOU, Sofia
GIANNOU, Haralambos
BIBA, Angeliki
PALLIDI, Stella
CHRISTODOULOU, Angeliki
MAILLIS, Antonis
RABAVILAS, Andreas
description This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation. Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received 20 injections of fluoxetine, a matched pair saline, both followed by 4 days of meta-chlorophenylpiperazine (mCPP) challenge. Experiment 2: Five matched groups of rats (n = 9) received pretreatment (20 injections) with fluoxetine, mCPP, desipramine, diazepam or saline, followed by 4 days of mCPP challenge (fluoxetine in mCPP group). After washout, animals received 2 days of naratriptan, followed by another 2-day mCPP challenge. In both experiments mCPP significantly increased persistence in saline controls. Fluoxetine also acutely increased persistence scores: after a gradual return to baseline, these scores showed tolerance to mCPP. Experiment 1: This pattern was significant in high but not low initial persistence groups. Experiment 2: Fluoxetine and mCPP showed cross-tolerance. Neither desipramine nor diazepam protected against mCPP challenge. Persistence scores returned to baseline during washout and naratriptan and were thereafter increased by another mCPP challenge in all but the fluoxetine and mCPP groups, suggesting 5-HT2C receptor mediation. This model is based on spontaneous persistence behavior showing pharmacological responses concordant with those of compulsive symptomatology.
doi_str_mv 10.1016/j.biopsych.2005.02.020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67788868</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67788868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-d3618c3938bfc1f2e653dd2c7878a89c5eaedd705bb06020217e6d6ba6153f403</originalsourceid><addsrcrecordid>eNpFUU1vEzEQ3QOoLS1_ofIFBIcN_sBehxtKgVaqVKkqZ8trzzaOvPbi2UTKT-Jf1iFBlUb2G_nNm_G8prlmdMEoU182iz7kCfduveCUygXlNeib5oJSqlrBuThv3iFuatpxzs6acya1UlLqi-bvI4Q05OLAE5zsHGwkNs5QUsU5EYvE1jOFsT6M2UMkeSC5R0AMO2hdHqdtPEDiA-bioZBPD6ubz-QbuUs7wDk8H5VqmWxvn_iqqvl_kN2QAg6mORcS0i7HHYyQ5opJVSB1mnWe1nsMOebn_VXzdrAR4f3pvmx-__zxtLpt7x9-3a2-37dOiOXceqGYdmIpdD84NnBQUnjPXac7bfXSSbDgfUdl31NV18RZB8qr3iomxfCVisvm41F3KvnPtn7AjAEdxGgT5C0a1XVaa6UrUR2JrmTEAoOZSl1T2RtGzcEYszH_jTEHYwzlNQ4drk8dtv0I_rXs5EolfDgRLDobh2KTC_jKU3UCQal4AQntnWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67788868</pqid></control><display><type>article</type><title>Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>TSALTAS, Eleftheria ; KONTIS, Dimitris ; CHRYSIKAKOU, Sofia ; GIANNOU, Haralambos ; BIBA, Angeliki ; PALLIDI, Stella ; CHRISTODOULOU, Angeliki ; MAILLIS, Antonis ; RABAVILAS, Andreas</creator><creatorcontrib>TSALTAS, Eleftheria ; KONTIS, Dimitris ; CHRYSIKAKOU, Sofia ; GIANNOU, Haralambos ; BIBA, Angeliki ; PALLIDI, Stella ; CHRISTODOULOU, Angeliki ; MAILLIS, Antonis ; RABAVILAS, Andreas</creatorcontrib><description>This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation. Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received 20 injections of fluoxetine, a matched pair saline, both followed by 4 days of meta-chlorophenylpiperazine (mCPP) challenge. Experiment 2: Five matched groups of rats (n = 9) received pretreatment (20 injections) with fluoxetine, mCPP, desipramine, diazepam or saline, followed by 4 days of mCPP challenge (fluoxetine in mCPP group). After washout, animals received 2 days of naratriptan, followed by another 2-day mCPP challenge. In both experiments mCPP significantly increased persistence in saline controls. Fluoxetine also acutely increased persistence scores: after a gradual return to baseline, these scores showed tolerance to mCPP. Experiment 1: This pattern was significant in high but not low initial persistence groups. Experiment 2: Fluoxetine and mCPP showed cross-tolerance. Neither desipramine nor diazepam protected against mCPP challenge. Persistence scores returned to baseline during washout and naratriptan and were thereafter increased by another mCPP challenge in all but the fluoxetine and mCPP groups, suggesting 5-HT2C receptor mediation. This model is based on spontaneous persistence behavior showing pharmacological responses concordant with those of compulsive symptomatology.</description><identifier>ISSN: 0006-3223</identifier><identifier>DOI: 10.1016/j.biopsych.2005.02.020</identifier><identifier>PMID: 15866558</identifier><identifier>CODEN: BIPCBF</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Animals ; Anti-Anxiety Agents - pharmacology ; Antidepressive Agents, Tricyclic - pharmacology ; Behavioral psychophysiology ; Biological and medical sciences ; Desipramine - pharmacology ; Diazepam - pharmacology ; Disease Models, Animal ; Fluoxetine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Indoles - pharmacology ; Male ; Maze Learning - physiology ; Miscellaneous ; Obsessive-Compulsive Disorder - physiopathology ; Obsessive-Compulsive Disorder - psychology ; Piperazines - pharmacology ; Piperidines - pharmacology ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Rats ; Rats, Wistar ; Receptor, Serotonin, 5-HT1D - physiology ; Receptor, Serotonin, 5-HT2C - physiology ; Reinforcement (Psychology) ; Serotonin Receptor Agonists - pharmacology ; Serotonin Uptake Inhibitors - pharmacology ; Tryptamines</subject><ispartof>Biological psychiatry (1969), 2005-05, Vol.57 (10), p.1176-1185</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-d3618c3938bfc1f2e653dd2c7878a89c5eaedd705bb06020217e6d6ba6153f403</citedby><cites>FETCH-LOGICAL-c339t-d3618c3938bfc1f2e653dd2c7878a89c5eaedd705bb06020217e6d6ba6153f403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16788300$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15866558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TSALTAS, Eleftheria</creatorcontrib><creatorcontrib>KONTIS, Dimitris</creatorcontrib><creatorcontrib>CHRYSIKAKOU, Sofia</creatorcontrib><creatorcontrib>GIANNOU, Haralambos</creatorcontrib><creatorcontrib>BIBA, Angeliki</creatorcontrib><creatorcontrib>PALLIDI, Stella</creatorcontrib><creatorcontrib>CHRISTODOULOU, Angeliki</creatorcontrib><creatorcontrib>MAILLIS, Antonis</creatorcontrib><creatorcontrib>RABAVILAS, Andreas</creatorcontrib><title>Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology</title><title>Biological psychiatry (1969)</title><addtitle>Biol Psychiatry</addtitle><description>This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation. Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received 20 injections of fluoxetine, a matched pair saline, both followed by 4 days of meta-chlorophenylpiperazine (mCPP) challenge. Experiment 2: Five matched groups of rats (n = 9) received pretreatment (20 injections) with fluoxetine, mCPP, desipramine, diazepam or saline, followed by 4 days of mCPP challenge (fluoxetine in mCPP group). After washout, animals received 2 days of naratriptan, followed by another 2-day mCPP challenge. In both experiments mCPP significantly increased persistence in saline controls. Fluoxetine also acutely increased persistence scores: after a gradual return to baseline, these scores showed tolerance to mCPP. Experiment 1: This pattern was significant in high but not low initial persistence groups. Experiment 2: Fluoxetine and mCPP showed cross-tolerance. Neither desipramine nor diazepam protected against mCPP challenge. Persistence scores returned to baseline during washout and naratriptan and were thereafter increased by another mCPP challenge in all but the fluoxetine and mCPP groups, suggesting 5-HT2C receptor mediation. This model is based on spontaneous persistence behavior showing pharmacological responses concordant with those of compulsive symptomatology.</description><subject>Animals</subject><subject>Anti-Anxiety Agents - pharmacology</subject><subject>Antidepressive Agents, Tricyclic - pharmacology</subject><subject>Behavioral psychophysiology</subject><subject>Biological and medical sciences</subject><subject>Desipramine - pharmacology</subject><subject>Diazepam - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Fluoxetine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Indoles - pharmacology</subject><subject>Male</subject><subject>Maze Learning - physiology</subject><subject>Miscellaneous</subject><subject>Obsessive-Compulsive Disorder - physiopathology</subject><subject>Obsessive-Compulsive Disorder - psychology</subject><subject>Piperazines - pharmacology</subject><subject>Piperidines - pharmacology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptor, Serotonin, 5-HT1D - physiology</subject><subject>Receptor, Serotonin, 5-HT2C - physiology</subject><subject>Reinforcement (Psychology)</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>Serotonin Uptake Inhibitors - pharmacology</subject><subject>Tryptamines</subject><issn>0006-3223</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFUU1vEzEQ3QOoLS1_ofIFBIcN_sBehxtKgVaqVKkqZ8trzzaOvPbi2UTKT-Jf1iFBlUb2G_nNm_G8prlmdMEoU182iz7kCfduveCUygXlNeib5oJSqlrBuThv3iFuatpxzs6acya1UlLqi-bvI4Q05OLAE5zsHGwkNs5QUsU5EYvE1jOFsT6M2UMkeSC5R0AMO2hdHqdtPEDiA-bioZBPD6ubz-QbuUs7wDk8H5VqmWxvn_iqqvl_kN2QAg6mORcS0i7HHYyQ5opJVSB1mnWe1nsMOebn_VXzdrAR4f3pvmx-__zxtLpt7x9-3a2-37dOiOXceqGYdmIpdD84NnBQUnjPXac7bfXSSbDgfUdl31NV18RZB8qr3iomxfCVisvm41F3KvnPtn7AjAEdxGgT5C0a1XVaa6UrUR2JrmTEAoOZSl1T2RtGzcEYszH_jTEHYwzlNQ4drk8dtv0I_rXs5EolfDgRLDobh2KTC_jKU3UCQal4AQntnWA</recordid><startdate>20050515</startdate><enddate>20050515</enddate><creator>TSALTAS, Eleftheria</creator><creator>KONTIS, Dimitris</creator><creator>CHRYSIKAKOU, Sofia</creator><creator>GIANNOU, Haralambos</creator><creator>BIBA, Angeliki</creator><creator>PALLIDI, Stella</creator><creator>CHRISTODOULOU, Angeliki</creator><creator>MAILLIS, Antonis</creator><creator>RABAVILAS, Andreas</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050515</creationdate><title>Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology</title><author>TSALTAS, Eleftheria ; KONTIS, Dimitris ; CHRYSIKAKOU, Sofia ; GIANNOU, Haralambos ; BIBA, Angeliki ; PALLIDI, Stella ; CHRISTODOULOU, Angeliki ; MAILLIS, Antonis ; RABAVILAS, Andreas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-d3618c3938bfc1f2e653dd2c7878a89c5eaedd705bb06020217e6d6ba6153f403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Anti-Anxiety Agents - pharmacology</topic><topic>Antidepressive Agents, Tricyclic - pharmacology</topic><topic>Behavioral psychophysiology</topic><topic>Biological and medical sciences</topic><topic>Desipramine - pharmacology</topic><topic>Diazepam - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Fluoxetine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Indoles - pharmacology</topic><topic>Male</topic><topic>Maze Learning - physiology</topic><topic>Miscellaneous</topic><topic>Obsessive-Compulsive Disorder - physiopathology</topic><topic>Obsessive-Compulsive Disorder - psychology</topic><topic>Piperazines - pharmacology</topic><topic>Piperidines - pharmacology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptor, Serotonin, 5-HT1D - physiology</topic><topic>Receptor, Serotonin, 5-HT2C - physiology</topic><topic>Reinforcement (Psychology)</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>Serotonin Uptake Inhibitors - pharmacology</topic><topic>Tryptamines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TSALTAS, Eleftheria</creatorcontrib><creatorcontrib>KONTIS, Dimitris</creatorcontrib><creatorcontrib>CHRYSIKAKOU, Sofia</creatorcontrib><creatorcontrib>GIANNOU, Haralambos</creatorcontrib><creatorcontrib>BIBA, Angeliki</creatorcontrib><creatorcontrib>PALLIDI, Stella</creatorcontrib><creatorcontrib>CHRISTODOULOU, Angeliki</creatorcontrib><creatorcontrib>MAILLIS, Antonis</creatorcontrib><creatorcontrib>RABAVILAS, Andreas</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biological psychiatry (1969)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TSALTAS, Eleftheria</au><au>KONTIS, Dimitris</au><au>CHRYSIKAKOU, Sofia</au><au>GIANNOU, Haralambos</au><au>BIBA, Angeliki</au><au>PALLIDI, Stella</au><au>CHRISTODOULOU, Angeliki</au><au>MAILLIS, Antonis</au><au>RABAVILAS, Andreas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology</atitle><jtitle>Biological psychiatry (1969)</jtitle><addtitle>Biol Psychiatry</addtitle><date>2005-05-15</date><risdate>2005</risdate><volume>57</volume><issue>10</issue><spage>1176</spage><epage>1185</epage><pages>1176-1185</pages><issn>0006-3223</issn><coden>BIPCBF</coden><abstract>This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation. Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received 20 injections of fluoxetine, a matched pair saline, both followed by 4 days of meta-chlorophenylpiperazine (mCPP) challenge. Experiment 2: Five matched groups of rats (n = 9) received pretreatment (20 injections) with fluoxetine, mCPP, desipramine, diazepam or saline, followed by 4 days of mCPP challenge (fluoxetine in mCPP group). After washout, animals received 2 days of naratriptan, followed by another 2-day mCPP challenge. In both experiments mCPP significantly increased persistence in saline controls. Fluoxetine also acutely increased persistence scores: after a gradual return to baseline, these scores showed tolerance to mCPP. Experiment 1: This pattern was significant in high but not low initial persistence groups. Experiment 2: Fluoxetine and mCPP showed cross-tolerance. Neither desipramine nor diazepam protected against mCPP challenge. Persistence scores returned to baseline during washout and naratriptan and were thereafter increased by another mCPP challenge in all but the fluoxetine and mCPP groups, suggesting 5-HT2C receptor mediation. This model is based on spontaneous persistence behavior showing pharmacological responses concordant with those of compulsive symptomatology.</abstract><cop>New York, NY</cop><pub>Elsevier Science</pub><pmid>15866558</pmid><doi>10.1016/j.biopsych.2005.02.020</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-3223
ispartof Biological psychiatry (1969), 2005-05, Vol.57 (10), p.1176-1185
issn 0006-3223
language eng
recordid cdi_proquest_miscellaneous_67788868
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Anti-Anxiety Agents - pharmacology
Antidepressive Agents, Tricyclic - pharmacology
Behavioral psychophysiology
Biological and medical sciences
Desipramine - pharmacology
Diazepam - pharmacology
Disease Models, Animal
Fluoxetine - pharmacology
Fundamental and applied biological sciences. Psychology
Indoles - pharmacology
Male
Maze Learning - physiology
Miscellaneous
Obsessive-Compulsive Disorder - physiopathology
Obsessive-Compulsive Disorder - psychology
Piperazines - pharmacology
Piperidines - pharmacology
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Rats
Rats, Wistar
Receptor, Serotonin, 5-HT1D - physiology
Receptor, Serotonin, 5-HT2C - physiology
Reinforcement (Psychology)
Serotonin Receptor Agonists - pharmacology
Serotonin Uptake Inhibitors - pharmacology
Tryptamines
title Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T05%3A16%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reinforced%20spatial%20alternation%20as%20an%20animal%20model%20of%20obsessive-compulsive%20disorder%20(OCD)%20:%20Investigation%20of%205-HT2C%20and%205-HT1D%20receptor%20involvement%20in%20OCD%20pathophysiology&rft.jtitle=Biological%20psychiatry%20(1969)&rft.au=TSALTAS,%20Eleftheria&rft.date=2005-05-15&rft.volume=57&rft.issue=10&rft.spage=1176&rft.epage=1185&rft.pages=1176-1185&rft.issn=0006-3223&rft.coden=BIPCBF&rft_id=info:doi/10.1016/j.biopsych.2005.02.020&rft_dat=%3Cproquest_cross%3E67788868%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67788868&rft_id=info:pmid/15866558&rfr_iscdi=true